Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Many radiology PowerPoints inadvertently put private health information at risk

Many of these files are still readily available online, and numerous contain PHI that is “easily accessible,” a new analysis reveals.

Stock image of an illegal bribe.

California imaging clinics at center of $54M Medicare fraud scandal

The LA area duo at the helm of the scheme laundered their profits “by buying millions of dollars’ worth of gold bars and coins,” the DOJ says.

An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’

In a more perfect world, legal cases against radiologists would solely focus on whether or not the defendant’s misdiagnosis reflected a true failure to uphold the standard of care. 

HeartFlow Plaque Analysis

CMS updates Medicare coverage for AI-powered coronary plaque assessments

The new policy goes into effect in November, improving Medicare coverage for a technology that has rapidly gained momentum in recent years.

Thumbnail

Teva settles with DOJ for $450M to resolve latest price fixing allegations

The world's largest generic drug manufacturer allegedly paid charities kickbacks to cover patient co-pays in an effort to inflate the price tag of its multiple sclerosis treatment.

Elizabeth Warren

Members of Congress introduce bill to halt private equity ‘looting’ of healthcare entities

The Stop Wall Street Looting Act closes regulatory loopholes and ends incentives that allow investors to “pillage” acquired businesses, Sen. Elizabeth Warren and colleagues note.  

pharmaceutical drug approval process

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

money maze benjamin franklin reimbursement medicare

Radiologists and other physicians reject proposal to consolidate MAC jurisdictions

CMS sent out its request for information in September, mulling the possibility of reducing 4 Medicare Administrative Contractor districts down to 2.